… with advanced gastric or gastroesophageal cancer (AGC) that is … immune-based and targeted
therapy combinations. To provide a … Our findings suggest that FGFR2b-targeted therapy, …

… dying from cancer is increasing in a very threatening way. In-silico analysis has done
using software and we further targeted some of the genes responsible for Gastric Cancer and …

… (mAb) trastuzumab (Herceptin®) for the targeted therapy of a subset of patients with genetic
… expected from this therapeutic agent.Two other targeted therapies have been recently …

… and have been/are in targeted therapy clinical trials and, which … Some gastric cancer
biomarkers that may help in defining the … targeted and conventional systemic therapies may …

… targeting therapy will increase the survival rates of patients with advanced or recurrent gastric
cancer… Here, we describe molecular targeting therapy for gastric cancer and review clinical …

… of therapy for gastric cancer. When implementing CD9-targeted therapy in gastric cancer, we
… A new therapy to target HER2, VEGFR-2, is responsible for a significant increase in survival …

… Forty GC patients received HER2-targeted therapy or HER2-targeted therapy plus chemotherapy
were enrolled in this study, with a median age of 59 (29-75 years). Thirty-one patients (…

… Antiepidermal growth factor receptor (EGFR) and antiangiogenic therapies are being tested
… on targeted therapies in advanced gastric cancer. Gastric cancer: a heterogeneous disease …

… ) and (“target-based agents” or “targeted therapies” or “targeted drugs” or “targeted agents”
or … the efficacy and safety of targeted therapies in metastatic gastric cancer (ie, reporting the …

… of various drugs that particularly target the various genes and signaling pathways. Our review
summarizes the recent molecular targeted therapies in advanced stages of gastric cancer. …